Q4 earnings season is still a few weeks away, with several IBD 50 firms, including Palantir stock, still in major growth mode ...

AppLovin is the IBD Stock Of The Day as the app marketing platform earns positive reviews for its nascent e-commerce ...

Israel's Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and ...

Duvakitug was generally well tolerated across patient groups and showed similar rates of treatment-emergent adverse events, ...

ORLANDO -- Major cardiovascular event risk in patients with inflammatory bowel disease (IBD) was no greater with Janus kinase ...

As Merck and Roche continue to march their respective inflammatory bowel disease (IBD) assets through the clinic, Sanofi and ...

The trial was investigating the use of vagus nerve stimulation (VNS) for inflammatory bowel disease (IBD), an autoimmune ...

The anti-TL1A antibody allowed significantly more inflammatory bowel disease (IBD) patients to go into remission than those ...

More than half (62.7%) of respondents reported facing financial barriers to obtaining their IBD medication.

ORLANDO -- Longer hospitalization for flares of inflammatory bowel disease (IBD) was linked to greater risk of subsequent ...

GET MORE AI-GENERATED SIGNALS: December 15, 2024, 01:48 am ET, BY Tom S.- Contributor| Editor: Thomas H. Kee Jr. ( Follow on ...

Ira Daniel Breite, MD, is a board-certified internist and gastroenterologist. He is an associate professor at the Icahn ...